Follow G1 Therapeutics as it advances trilaciclib in Phase 3 PRESERVE 2 trial for metastatic triple-negative breast cancer. Updates on trial progress, interim analysis, and potential FDA filing in 2024.
Shares of Lattice Semiconductor Corp (NASDAQ: LSCC) recovered slightly in early trading on Tuesday, after the company reported mixed results for the four
Diamondback Energy Inc (NASDAQ: FANG) disclosed a definitive merger deal with Endeavor Energy Resources, L.P. for around $26 billion, inclusive of Endeavor’s net debt.
Shares of Lowe's Companies Inc (NYSE: LOW) slipped in early trading on Tuesday.
The pressure on the share of wallet for goods seem to be subsiding, with a resumption in wage growth, according to JPMorgan analyst Christopher Horvers.